An alternative means of stopping tuberculosis, leprosy and other bacterial illness may be forthcoming.
Researchers from Weill Cornell Medical College in New York City say exciting new molecular targets - so-called "virulence factors" that bacteria use to thrive once they are in the host - present a potent means of stopping TB, leprosy and other bacterial illness
